Article By:
ChinaBio® Today
Saturday, December 9, 2017 4:13 PM EDT
Pfizer (NYSE: PFE) signed a $226 million agreement for China/Asian rights to Cresemba® (isavuconazole), an antifungal drug and Everest Medicines announced a $224 million partnership with San Diego's Arena Pharma.